EA200100407A1 - Кристалл диуридин тетрафосфата или его соли и способ его получения и способ получения указанного соединения - Google Patents
Кристалл диуридин тетрафосфата или его соли и способ его получения и способ получения указанного соединенияInfo
- Publication number
- EA200100407A1 EA200100407A1 EA200100407A EA200100407A EA200100407A1 EA 200100407 A1 EA200100407 A1 EA 200100407A1 EA 200100407 A EA200100407 A EA 200100407A EA 200100407 A EA200100407 A EA 200100407A EA 200100407 A1 EA200100407 A1 EA 200100407A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- salt
- ump
- dfp
- preparation
- crystals
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 5
- 239000013078 crystal Substances 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 abstract 4
- YDHWWBZFRZWVHO-UHFFFAOYSA-H [oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O YDHWWBZFRZWVHO-UHFFFAOYSA-H 0.000 abstract 3
- 239000003513 alkali Substances 0.000 abstract 3
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 abstract 2
- 230000003993 interaction Effects 0.000 abstract 2
- 239000007858 starting material Substances 0.000 abstract 2
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 abstract 2
- 229940045145 uridine Drugs 0.000 abstract 2
- 239000002585 base Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- ASMQGLCHMVWBQR-UHFFFAOYSA-M diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)([O-])OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-M 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Настоящее изобретение раскрывает кристаллы P,P-ди(уридин 5'-)тетрафосфата или его соли; способ получения кристаллов и способ получения P,P-ди(уридин 5'-)тетрафосфата (UP) или его соли из УМФ, служащего в качестве исходного вещества, и с использованием ДХФ и ПФ, включающий, по меньшей мере, одну из следующих стадий обработки: (a) добавление УМФ дифенилфосфата (УМФ-ДФФ) отдельными порциями во время стадии взаимодействия УМФ-ДФФ с солью ПФ-органической щелочи; (b) проведение стадии взаимодействия УМФ-ДФФ с солью ПФ-органической щелочи в присутствии основания и (c) дальнейшую обработку синтезированного UPщелочью. Кристаллы UPили его соли, полученные по способу в соответствии с изобретением, имеют высокую чистоту и стабильность и меньшую гигроскопичность по сравнению с лиофилизованным продуктом, для того чтобы служить, таким образом, полезным исходным веществом для получения фармацевтического препарата. Способ получения UPили его соли в соответствии с изобретением осуществляется с высоким выходом и делает возможным крупномасштабный синтез.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28166398 | 1998-10-02 | ||
| JP17068199 | 1999-06-17 | ||
| PCT/JP1999/005415 WO2000020430A1 (fr) | 1998-10-02 | 1999-10-01 | Cristal de diuridine tetraphosphate ou sel correspondant et procede de fabrication |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200100407A1 true EA200100407A1 (ru) | 2001-10-22 |
| EA003167B1 EA003167B1 (ru) | 2003-02-27 |
Family
ID=26493605
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200200695A EA004513B1 (ru) | 1998-10-02 | 1999-10-01 | Способ получения диуридинтетрафосфата или его соли |
| EA200100407A EA003167B1 (ru) | 1998-10-02 | 1999-10-01 | Кристалл диуридин тетрафосфата или его соли и способ его получения и способ получения указанного соединения |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200200695A EA004513B1 (ru) | 1998-10-02 | 1999-10-01 | Способ получения диуридинтетрафосфата или его соли |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6458946B1 (ru) |
| EP (1) | EP1043329B1 (ru) |
| JP (2) | JP3247685B2 (ru) |
| KR (1) | KR100475008B1 (ru) |
| CN (2) | CN100396692C (ru) |
| AT (1) | ATE222920T1 (ru) |
| AU (1) | AU747096C (ru) |
| BR (2) | BRPI9917911B1 (ru) |
| CA (1) | CA2345624C (ru) |
| CZ (1) | CZ300402B6 (ru) |
| DE (1) | DE69902624T2 (ru) |
| EA (2) | EA004513B1 (ru) |
| ES (1) | ES2183650T3 (ru) |
| HU (1) | HU228681B1 (ru) |
| IL (1) | IL142181A (ru) |
| MX (1) | MXPA01003377A (ru) |
| NO (1) | NO317305B1 (ru) |
| NZ (1) | NZ510748A (ru) |
| PL (1) | PL199434B1 (ru) |
| SK (1) | SK283729B6 (ru) |
| WO (1) | WO2000020430A1 (ru) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7223744B2 (en) | 1997-02-10 | 2007-05-29 | Inspire Pharmaceuticals, Inc. | Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof |
| US6818629B2 (en) | 1997-02-10 | 2004-11-16 | Inspire Pharmaceuticals, Inc. | Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate |
| US7078391B2 (en) * | 1997-02-10 | 2006-07-18 | Inspire Pharmaceuticals, Inc. | Method of treating edematous retinal disorders |
| US6872710B2 (en) | 1997-07-25 | 2005-03-29 | Inspire Pharmaceuticals, Inc. | Di(uridine 5′)-tetraphosphate and salts thereof |
| DE60006814T2 (de) * | 1999-06-30 | 2004-05-19 | Yamasa Corp., Choshi | Dinucleotid-kristalle |
| US6867199B2 (en) | 2000-08-21 | 2005-03-15 | Inspire Pharmaceuticals, Inc. | Dinucleoside polyphosphate compositions and their therapeutic use |
| CN100363376C (zh) * | 2006-06-12 | 2008-01-23 | 南京工业大学 | 一种5’-核苷三磷酸钠盐的结晶方法 |
| US10493091B2 (en) * | 2015-06-29 | 2019-12-03 | Yamasa Corporation | Method for storing P1, P4-bis(5′-uridyl)teraphosphate crystals |
| HUE055280T2 (hu) * | 2016-10-25 | 2021-11-29 | Yamasa Corp | Eljárás P1, P4-di(uridin-5'-)tetrafoszfát tisztítására |
| KR20180091689A (ko) | 2017-11-06 | 2018-08-16 | 주식회사 종근당 | 무정형 디뉴클레오사이드 폴리포스페이트 화합물의 제조방법 |
| CN109021049B (zh) * | 2018-06-14 | 2020-12-08 | 扬子江药业集团北京海燕药业有限公司 | 一种尿苷5′-二磷酸-苯并咪唑二钠的合成方法 |
| KR20210110055A (ko) * | 2020-02-28 | 2021-09-07 | 주식회사 종근당바이오 | P1, p4-디(우리딘 5'-)테트라포스페이트 나트륨염 4 수화물 결정형 a의 제조방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6423694B1 (en) * | 1996-02-21 | 2002-07-23 | Inspire Pharmaceuticals, Inc. | Method of treating otitis media with uridine triphosphates and related compounds |
| CN1229114C (zh) * | 1996-03-27 | 2005-11-30 | 印斯拜尔药品股份有限公司 | 用三磷酸尿苷和相关化合物治疗纤毛运动障碍的方法 |
| US6319908B1 (en) * | 1996-07-03 | 2001-11-20 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof |
| US5763447C1 (en) * | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| EP1012154B1 (en) * | 1997-07-25 | 2004-03-17 | Inspire Pharmaceuticals, Inc. | Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
-
1999
- 1999-10-01 HU HU0103754A patent/HU228681B1/hu unknown
- 1999-10-01 CA CA002345624A patent/CA2345624C/en not_active Expired - Lifetime
- 1999-10-01 ES ES99970090T patent/ES2183650T3/es not_active Expired - Lifetime
- 1999-10-01 EA EA200200695A patent/EA004513B1/ru not_active IP Right Cessation
- 1999-10-01 IL IL14218199A patent/IL142181A/xx not_active IP Right Cessation
- 1999-10-01 NZ NZ510748A patent/NZ510748A/xx not_active IP Right Cessation
- 1999-10-01 CN CNB2003101209181A patent/CN100396692C/zh not_active Expired - Lifetime
- 1999-10-01 AT AT99970090T patent/ATE222920T1/de not_active IP Right Cessation
- 1999-10-01 KR KR10-2001-7004083A patent/KR100475008B1/ko active IP Right Grant
- 1999-10-01 CN CNB998117137A patent/CN1151166C/zh not_active Expired - Lifetime
- 1999-10-01 DE DE69902624T patent/DE69902624T2/de not_active Expired - Lifetime
- 1999-10-01 EA EA200100407A patent/EA003167B1/ru not_active IP Right Cessation
- 1999-10-01 BR BRPI9917911A patent/BRPI9917911B1/pt active IP Right Grant
- 1999-10-01 SK SK440-2001A patent/SK283729B6/sk not_active IP Right Cessation
- 1999-10-01 PL PL347070A patent/PL199434B1/pl unknown
- 1999-10-01 AU AU60008/99A patent/AU747096C/en not_active Expired
- 1999-10-01 WO PCT/JP1999/005415 patent/WO2000020430A1/ja active IP Right Grant
- 1999-10-01 EP EP99970090A patent/EP1043329B1/en not_active Expired - Lifetime
- 1999-10-01 CZ CZ20011028A patent/CZ300402B6/cs not_active IP Right Cessation
- 1999-10-01 US US09/582,642 patent/US6458946B1/en not_active Expired - Lifetime
- 1999-10-01 JP JP2000574541A patent/JP3247685B2/ja not_active Expired - Lifetime
- 1999-10-01 BR BR9914453-0A patent/BR9914453A/pt not_active Application Discontinuation
- 1999-10-01 MX MXPA01003377A patent/MXPA01003377A/es active IP Right Grant
-
2001
- 2001-03-30 NO NO20011634A patent/NO317305B1/no not_active IP Right Cessation
- 2001-08-06 JP JP2001237293A patent/JP3824894B2/ja not_active Expired - Lifetime
-
2002
- 2002-04-12 US US10/120,367 patent/US6780988B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200100407A1 (ru) | Кристалл диуридин тетрафосфата или его соли и способ его получения и способ получения указанного соединения | |
| EA200200109A1 (ru) | Кристаллы динуклеотида | |
| RU94046317A (ru) | Новое синтетическое промежуточное соединение для получения производных и способы получения производных аминокислот | |
| FI841886A0 (fi) | Vid detektering av ioner anvaendbar ny foerening och foerfarande foer dess framstaellning. | |
| EP0950664B1 (en) | Process for producing N-glycyltyrosine | |
| RU94046012A (ru) | Способ стереоспецифического гидролиза производных пиперидиндиона, продукт гидролиза и способ получения пароксетина | |
| Carey et al. | Resonance Raman spectra of chymotrypsin acyl enzymes | |
| JPH0689024B2 (ja) | ポリペプチド類の製造方法 | |
| Paquet et al. | Further studies on the synthesis of symmetrical anhydrides and 2, 4-disubstituted-5 (4 H)-oxazolones from N-alkoxycarbonylamino acids using soluble carbodiimide | |
| HUT40793A (en) | Process for preparing hexene-carboxylic acid derivatives | |
| Vinick et al. | A simple and efficient synthesis of L-carnosine | |
| EA200201202A1 (ru) | Циклические кетоны, их получение и их применение в синтезе аминокислот | |
| JP2009062392A (ja) | 環化法 | |
| MY105600A (en) | Aminocarbonyl-substituted pyridinesulfinic acid or salts thereof | |
| KR910000896B1 (ko) | dl-α-토코페릴 아세테이트의 제조방법 | |
| US5011974A (en) | Process for the preparation of derivative of 2-diethylamino-1-methylethyl-1-hydroxy-(bicyclohexyl)-2-carboxylate | |
| JPH03261743A (ja) | ジャスモン酸の光学分割方法 | |
| JPH0374347A (ja) | シス・トランス混合菊酸の光学分割法 | |
| JPH02191246A (ja) | Ｌ―アルギニナールジ低級アルキルアセタールの製造法 | |
| DE60008642D1 (de) | Verfahren zur Herstellung von optisch aktiven N-geschützten N-Methyl-phenylalanin-Derivaten | |
| JPH0285235A (ja) | 光学活性アミノアルコール類の製法 | |
| JPH053870B2 (ru) | ||
| RU94017615A (ru) | Способ получения пептида | |
| JPH0967293A (ja) | ２，３−ベンゾシクロアルケノンの製造法 | |
| JPH023628A (ja) | 光学活性１−メチル−３−フェニルプロピルアミンの製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Patent expired |
Designated state(s): RU |